Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 266-096-3 | CAS number: 66063-05-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Guideline-compliant studies of skin sensitisation in the Guinea pig (Buehler and Maximisation designs) are available and both show a lack of skin sensitisation for pencycuron. The Maximisation study is considered key as this method is generally considered to be more sensitive than the Buehler method (supporting), although both designs are scientifically valid. These two in vivo studies were performed prior to the validation and adoption of alternative methods.
Test Species/Type | Results | Assessment | Reference |
OECD 406 - Maximisation study | Pencycuron was not a skin sensitiser. | Key study | Heimann (1984) |
OECD 406 - Buehler study | Pencycuron was not a skin sensitiser. | Supporting study | Sheets (1989) |
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1984-06-29
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- The most important deviations from the guideline were: no results of a reliability check were provided; no results of the induction application were provided; the dose-selection is unclear
- GLP compliance:
- no
- Remarks:
- Older study, predates mandatory GLP
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The study was performed before the adoption of the OECD test guideline (OECD 429) for the LLNA, in 2010
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Remarks:
- DHPW
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 280 - 375 g.
- Housing: The animals were kept, five to a Makrolon cage type IV.
- Diet: Altromin 3022 Diet for guinea pigs, ad libitum
- Water: drinking water from bottles, ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature: 22-24° C
- Humidity: 30-50 %
- Photoperiod: light/dark rhythm 12 hours. - Route:
- intradermal
- Vehicle:
- other: Cremophor EL/physiological saline
- Concentration / amount:
- 1%
- Day(s)/duration:
- Day 1
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: Cremophor EL/physiological saline
- Concentration / amount:
- 25%
- Day(s)/duration:
- Topical induction was performed for 48 hours, one week after intradermal injection
- Adequacy of induction:
- other: Although the highest topical induction concentration of 25% w/v did not result in a skin reaction, this concentration is considered to be sufficient, as it is near the maximum concentration for powders to obtain a well-mixed suspension (ca. 30%).
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: Cremophor EL/physiological saline
- Concentration / amount:
- 25%
- Day(s)/duration:
- 24 hours
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- Three animal groups (one test compound and two control groups) each consisting of 20 male animals (test compound group) and ten males (control groups)
- Details on study design:
- RANGE FINDING TESTS:
The doses in the main study were based on the results of a range-finding study using 0, 1, 2.5, and 5% w/v (intradermal induction) and 3, 6, 12.5, and 25% w/v (topical induction). Although the effects induced by intradermal injection of the test concentrations were not indicated, the intradermal induction dose was determined to be 1% w/v.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal (3 sites) and topical)
- Exposure period: 48 hours for the topical induction
- Test groups: 1 test group of 20 males.
- Control group: 2 control groups of 10 males each.
- Site:
For the intradermal induction: Starting at the back of the neck, three intradermal injections were given parallel to each flank. The intervals between the injection sites were approx. 1- 2 cm.
For the topical induction: placed between or on the injection sites
- Concentrations: 1% Pencycuron in the intradermal induction, and 25% Pencycuron for the topical induction.
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 1 but observed up to 48 hours after exposure.
- Exposure period: 24 hours
- Test groups: 1 test group of 20 males.
- Control group: 1 control group of 10 males each.
- Site: on the left flank of the animals
- Concentrations: 25% Pencycuron.
- Evaluation (hr after challenge): 24 and 48 - Challenge controls:
- A hypoallergenic dressing soaked in the formulation vehicle was placed on the left flank of the animals in the first control group, and fastened to the skin with occlusive tape for 24 hours.
For comparison a similar control dressing was fastened to the right flank, and this had only been soaked with the formulation vehicle. - Positive control substance(s):
- no
- Positive control results:
- Not reported
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: vehicle control
- Dose level:
- 0%
- No. with + reactions:
- 1
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: vehicle control
- Dose level:
- 0%
- No. with + reactions:
- 1
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- The incidence of animals with positive dermal reactions (10%) is marginally higher than the incidence of reactions to the vehicle (5%) and is not indicative of skin sensitisation.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 1
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- The incidence of animals with positive dermal reactions (10%) is marginally higher than the incidence of reactions to the vehicle (5%) and is not indicative of skin sensitisation.
- Reading:
- other: No details reported
- Group:
- positive control
- Remarks on result:
- not measured/tested
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Pencycuron is not sensitising to the skin of guinea pigs in this Maximisation test.
- Executive summary:
Pencycuron was investigated for possible skin-allergising potential with a sensitisation test on male guinea pigs (MAGNUSSON and KLIGMAN's maximisation test). Pilot tests to establish the dose indicated that the following concentrations of the test compound should be used in the study:
intradermal induction: 1 %
topical induction: 25 %
challenge: 25 %After the challenge one animal in the test compound group reacted positively according to the evaluation criteria, while the animals in the control group did not exhibit any alterations. The degree of intensity of the response in this animal was only slight. The reaction observed in the skin of one animal is not significant, as experience has shown that individual animals can react spontaneously in this way.
The results therefore indicate that the test compound does not have a skin-sensitising effect on guinea pigs.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1988-10-05 to 1989-07-25
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- See Principles of method if other than guideline.
- Principles of method if other than guideline:
- The study was not performed in accordance with OECD 406, because of the following deviations from the guideline:
too few test and control animals were used, the choice for the vehicle is unclear, because it caused effects on the skin, the dose-selection is unclear, the challenge exposure (24 hours) was too long, control animals did not receive the induction application.
The doses in the main study were based on the results of a range-finding study using 0.5, 1.0, 5.0, 10, 25, 50, and 100% (i.e. moistened with water) w/v topical applications. The vehicle and all test concentrations except the 100% concentration caused slight irritation of the skin. It was unclear if good skin contact was achieved at the 100% concentration. - GLP compliance:
- no
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- The study was performed before the adoption of the OECD test guideline (OECD 429) in 2010
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: ethanol and deionized water
- Concentration / amount:
- 50% suspension in 80% ethanol and deionized water (0.4 ml)
- Day(s)/duration:
- 0, 7, 14
- Adequacy of induction:
- not specified
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: ethanol and deionized water
- Concentration / amount:
- 50% suspension in 80% ethanol and deionized water (0.4 ml)
- Day(s)/duration:
- Day 27
- Adequacy of challenge:
- not specified
- No. of animals per dose:
- A total of 30 adult male Hartley albino guinea pigs were assigned to one of four groups: pencycuron test group (15 animals), pencycuron negative-induction control group (five animals), l-chloro-2, 4-dinitrobenzene (DNCB - positive control) test group (five animals) and DNCB negative-induction control group (five animals).
- Details on study design:
- The pencycuron was administered as a 50% suspension in 80% ethanol and deionized water (0.4 ml). Animals in the test groups received three topical induction applications of the appropriate formulation on study days 0, 7 and 14, followed by a 13-day "rest" period and a challenge application on day 27. Animals in the two negative-induction control groups (pencycuron and DNCB) received only the challenge dose on day 27. All induction and challenge sites were scored for erythema at approximately 24 and 48 hours after removal of the test substance. Two calculations were used to estimate the response following the challenge dose. The first, incidence, was defined as the number of animals showing responses of one or greater at either 24 or 48 hours divided by the number of animals tested. The second, severity, was defined as the mean of the test grades at 24 and 48 hours.
- Positive control substance(s):
- yes
- Remarks:
- 1-chloro-2, 4-dinitrobenzene (DNCB - positive control)
- Positive control results:
- Positive for sensitisation.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 15
- Remarks on result:
- no indication of skin sensitisation
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- Acceptability
The study is considered unacceptable, because of the deviations from the guideline. It should be noted that for a correct classification and labelling in accordance with EC regulations, a maximisation test is preferred with regard to the assessment of dermal sensitisation potential.
Conclusions
The study is considered unacceptable. - Executive summary:
The potential for pencycuron to produce a dermal sensitization response was tested in guinea pigs using the Buehler Topical Closed-Patch Technique. A total of 30 adult male Hartley albino guinea pigs were assigned to one of four groups: pencycuron test group (15 animals), pencycuron negative-induction control group (five animals), l-chloro-2, 4-dinitrobenzene (DNCB - positive control) test group (five animals) and DNCB negative-induction control group (five animals). The pencycuron was administered as a 50% suspension in 80% ethanol and deionized water (0.4 ml). Animals in the test groups received three topical induction applications of the appropriate formulation on study days 0, 7 and 14, followed by a 13-day "rest" period and a challenge application on day 27. Animals in the two negative-induction control groups (pencycuron and DNCB) received only the challenge dose on day 27. All induction and challenge sites were scored for erythema at approximately 24 and 48 hours after removal of the test substance. Two calculations were used to estimate the response following the challenge dose. The first, incidence, was defined as the number of animals showing responses of one or greater at either 24 or 48 hours divided by the number of animals tested. The second, severity, was defined as the mean of the test grades at 24 and 48 hours.
No erythema was observed at the dose site of any of the pencycuron test or control group animals after the challenge dose. The DNCB test animals had an incidence score of 1.0 and a severity score of 1.0 following the challenge dose. The DNCB produced no evidence of irritation at the dose site of the negative-induction control animals.
This negative response to a challenge dose indicates that pencycuron does not cause dermal sensitization. However the study is considered unacceptable, because of the deviations from the guideline. It should be noted that for a correct classification and labelling in accordance with EC regulations, a maximisation test is preferred with regard to the assessment of dermal sensitisation potential.
Referenceopen allclose all
No erythema was observed at the dose site of any of the pencycuron test or control group animals after the challenge dose. The DNCB test animals had an incidence score of 1.0 and a severity score of 1.0 following the challenge dose. The DNCB produced no evidence of irritation at the dose site of the negative-induction control animals.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The Maximisation study is considered key as this method is generally considered to be more sensitive than the Buehler method (supporting), although both designs are scientifically valid. These two in vivo studies were performed prior to the validation and adoption of alternative methods.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Guideline-compliant studies of skin sensitisation in the Guinea pig (Buehler and Maximisation designs) both show a lack of skin sensitisation for pencycuron. Pencycuron does not have a harmonised classification for skin sensitisation. The negative results in both studies show that pencycuron does not require classification for skin sensitisation in any CLP category.
No data are available for respiratory sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.